Found 16 matching trials
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh PHASE4 The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Show More Location
BIRDEM General Hospital
Learn More & Join Trial
Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus PHASE4 The purpose of this study is to investigate the success rate of a switch fr...
Show More Location
Diabetologische Schwerpunktpraxis Dr. Lorra / Dr. Bonnermann
Learn More & Join Trial
Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin PHASE3 The purpose of this study is to compare the effects of saxagliptin with tho...
Show More Location
Clinical Research Advantage, Inc
Learn More & Join Trial
Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2. PHASE2 A phase IV, randomized, double-blind, single center pilot study in subjects...
Show More Location
Department of Endocrinology and Metabolism, University of Pisa
Learn More & Join Trial
Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes PHASE4 The main purpose of this study is to evaluate whether saxagliptin or (and v...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Fatty Liver Study in Patients With Type II Diabetes PHASE4 The primary objective of this trial is to measure changes in hepatic lipid ...
Show More Location
University of Texas Medical Branch -Galveston
Learn More & Join Trial
A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration. PHASE1 A Study to Assess the Fed-state Bioequivalence of a Triple Fixed-Combinatio...
Show More Learn More & Join Trial
Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA) N/A GIOIA represents a multicenter pragmatic prospective cohort study, aimed at...
Show More Learn More & Join Trial
A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin PHASE3 This research study of subjects with inadequately controlled type 2 diabete...
Show More Learn More & Join Trial
Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient PHASE4 The purpose of this research study is to test the safety and efficacy of a ...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial